DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-02-20
DOI
10.1038/srep42876
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changing strategies for target therapy in gastric cancer
- (2016) Suk-young Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer
- (2016) T Taniguchi et al. Cell Death & Disease
- Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer
- (2016) Jing Chen et al. Scientific Reports
- Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
- (2015) Kevin M. Sokolowski et al. Anti-Cancer Agents in Medicinal Chemistry
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway
- (2015) Zhendong Wang et al. CANCER SCIENCE
- The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis
- (2015) M Sarkar et al. ONCOGENE
- Reciprocal expression of p-AMPKa and p-S6 is strongly associated with the prognosis of gastric cancer
- (2015) Zhendong Zheng et al. TUMOR BIOLOGY
- Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine
- (2015) Yoon Young Choi et al. YONSEI MEDICAL JOURNAL
- MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway
- (2014) Cheng Du et al. BMC CANCER
- A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond
- (2014) Carlos Gomez-Martín et al. CANCER LETTERS
- P68 RNA helicase as a molecular target for cancer therapy
- (2014) Ting-Yu Dai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- RNA Helicases DDX5 and DDX17 Dynamically Orchestrate Transcription, miRNA, and Splicing Programs in Cell Differentiation
- (2014) Etienne Dardenne et al. Cell Reports
- LKB1/AMPK/mTOR Signaling Pathway in Non-small-cell Lung Cancer
- (2013) Dong Han et al. Asian Pacific Journal of Cancer Prevention
- The DEAD box proteins DDX5 (p68) and DDX17 (p72): Multi-tasking transcriptional regulators
- (2013) Frances V. Fuller-Pace Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways
- (2013) Samaan Samaan et al. NUCLEIC ACIDS RESEARCH
- p68/DdX5 Supports β-Catenin & RNAP II during Androgen Receptor Mediated Transcription in Prostate Cancer
- (2013) Emma L. Clark et al. PLoS One
- DEAD box RNA helicase functions in cancer
- (2013) Frances V. Fuller-Pace RNA Biology
- p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF- B transcription factor p50
- (2012) R. Wang et al. NEURO-ONCOLOGY
- DDX5 Regulates DNA Replication and Is Required for Cell Proliferation in a Subset of Breast Cancer Cells
- (2012) Anthony Mazurek et al. Cancer Discovery
- (−)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68
- (2011) Tomoko Tanaka et al. FREE RADICAL BIOLOGY AND MEDICINE
- RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development
- (2011) Frances V Fuller-Pace et al. Future Oncology
- mTOR as a therapeutic target in patients with gastric cancer
- (2011) Salah-Eddin Al-Batran et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
- (2010) Gizeh Pérez-Tenorio et al. BREAST CANCER RESEARCH AND TREATMENT
- Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer
- (2009) G. Yu et al. CLINICAL CANCER RESEARCH
- The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth and is associated with improved survival in ERα-positive breast cancer
- (2009) N C Wortham et al. ONCOGENE
- The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators
- (2008) Frances V. Fuller-Pace et al. BIOCHEMICAL SOCIETY TRANSACTIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation